ÍøºìºÚÁÏ

Skip to main content
(352) 265-4845

Mark S Segal, MD, PhD : Research

Nephrologist (Kidney Specialist)

Photo of Mark S Segal
(352) 265-4845 MyUFÍøºìºÚÁÏ

Research at a glance

Top areas of exploration

  • Cells, Cultured , 19 publications
  • Biomarkers , 17 publications
  • Kidney Failure, Chronic , 16 publications
  • Hypertension , 16 publications

Research activity

161 publications

10,466 citations

Why is this important?

Active clinical trials

HyperQure RDN System

HQ-HTN-G01 is a prospective, multicenter, single arm, open label, early feasibility study to evaluate initial safety and device design concept of "HyperQureTM RDN System", laparoscopic renal denervation therapy, in patients with resistant…

Investigator
Mark S Segal
Status
Accepting Candidates
Ages
22 Years - 80 Years
Sexes
All
EASi-KIDNEY
Investigator
Mark S Segal
Status
Accepting Candidates
REGEN-006

The purpose of this study is to assess the safety and efficacy (including durability) of up to 2 REACT injections given 3 months (+30 days) apart and delivered percutaneously into biopsied and non-biopsied contralateral kidneys in participants with…

Investigator
Mark S Segal
Status
Accepting Candidates
Ages
30 Years - 80 Years
Sexes
All

My publications

161 publications

2016

A case of isolated renal involvement of polyarteritis nodosa successfully treated with steroid monotherapy.

BMJ case reports

•

2016

A Novel Mechanism for Generating the Interferon Signature in Lupus: Opsonization of Dead Cells by Complement and IgM.

Arthritis & rheumatology (Hoboken, N.J.)

•

2016

Acute and Chronic Kidney Disease and Cardiovascular Mortality After Major Surgery.

Annals of surgery

2016

Effects of Long-Term Type I Interferon on the Arterial Wall and Smooth Muscle Progenitor Cells Differentiation.

Arteriosclerosis, thrombosis, and vascular biology

•

2016

Nebivolol Effects on Nitric Oxide Levels, Blood Pressure, and Renal Function in Kidney Transplant Patients.

Journal of clinical hypertension (Greenwich, Conn.)

•